279 related articles for article (PubMed ID: 36854019)
1. Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Ali A; Madni A; Shah H; Jamshaid T; Jan N; Khan S; Khan MM; Mahmood MA
PLoS One; 2023; 18(2):e0281004. PubMed ID: 36854019
[TBL] [Abstract][Full Text] [Related]
2. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
5. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
6. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
[TBL] [Abstract][Full Text] [Related]
7. Sulconazole-Loaded Solid Lipid Nanoparticles for Enhanced Antifungal Activity: In Vitro and In Vivo Approach.
Samee A; Usman F; Wani TA; Farooq M; Shah HS; Javed I; Ahmad H; Khan R; Zargar S; Kausar S
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005230
[TBL] [Abstract][Full Text] [Related]
8. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
9. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery.
Ramzan M; Gourion-Arsiquaud S; Hussain A; Gulati JS; Zhang Q; Trehan S; Puri V; Michniak-Kohn B; Kaur IP
Drug Deliv Transl Res; 2022 Jul; 12(7):1659-1683. PubMed ID: 34993923
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS
Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Dasgupta S; Ghosh SK; Ray S; Mazumder B
Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
[TBL] [Abstract][Full Text] [Related]
12. Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: Optimization, characterization and cytotoxicity evaluation.
Kaur R; Sharma N; Tikoo K; Sinha VR
Int J Pharm; 2020 Aug; 586():119439. PubMed ID: 32622808
[TBL] [Abstract][Full Text] [Related]
13. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting.
Jain SK; Chaurasiya A; Gupta Y; Jain A; Dagur P; Joshi B; Katoch VM
J Microencapsul; 2008 Aug; 25(5):289-97. PubMed ID: 18608808
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery.
Korkm E; Gokce EH; Ozer O
Acta Pharm; 2013 Dec; 63(4):517-29. PubMed ID: 24451076
[TBL] [Abstract][Full Text] [Related]
17. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
19. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
[TBL] [Abstract][Full Text] [Related]
20. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
